AlphaFold predicted structure
NOS2 · P35228

Mean pLDDT
85.4/ 100
Confident
1,153 residues
Confidence breakdown
- Very high(≥ 90)65%
- Confident(70–90)22%
- Low(50–70)4%
- Very low(< 50)9%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
nitric oxide synthase 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalFamilial Meniere Disease
Primary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalpsoriasis
psoriasis vulgaris
psoriatic arthritis
type 2 diabetes mellitus
chronic atrophic gastritis
myocardial infarction
skin disorder
acute myocardial infarction
ankylosing spondylitis
neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Nitric oxide synthase, inducible
Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body (PubMed:7504305, PubMed:7531687, PubMed:7544004, PubMed:7682706). In macrophages, NO mediates tumoricidal and bactericidal actions. Also has nitrosylase activity and mediates cysteine S-nitrosylation of cytoplasmic target proteins such PTGS2/COX2 (By similarity). As component of the iNOS-S100A8/9 transnitrosylase complex involved in the selective inflammatory stimulus-dependent S-nitrosylation of GAPDH on 'Cys-247' implicated in regulation of the GAIT complex activity and probably multiple targets including ANXA5, EZR, MSN and VIM (PubMed:25417112). Involved in inflammation, enhances the synthesis of pro-inflammatory mediators such as IL6 and IL8 (PubMed:19688109)
NOS2 · P35228

Mean pLDDT
85.4/ 100
Confident
1,153 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0